34095485|t|Lithium-Associated Hyperparathyroidism Followed by Catatonia.
34095485|a|OBJECTIVE: To familiarize the medical community with the less common adverse effects of lithium on parathyroid function, we present a case of lithium-associated hyperparathyroidism followed by the development of new-onset catatonia in a patient with schizoaffective disorder. METHODS: To allow for the safe resumption of lithium, the patient received laboratory screening of serum lithium, blood urea nitrogen, serum creatinine, calcium, and thyroid-stimulating hormone levels. The hypercalcemia was evaluated by measuring parathyroid hormone (PTH), ionized calcium, and 25-hydroxy vitamin D levels. RESULTS: A 58-year-old man with longstanding schizoaffective disorder was admitted for worsening psychotic symptoms following noncompliance with his risperidone and lithium regimen. Exploratory laboratory tests (hospital day 5) showed an elevated PTH level of 72 (reference, 15-65) pg/mL, ionized calcium level of 1.4 (reference, 1.03-1.23) mmol/mL, and a serum calcium level of 11.3 (reference, 8.4-10.5) mg/dL. After the discontinuation of lithium (day 6), anergia (day 7), mutism, and posturing (day 10) developed. Worsening catatonic symptoms of negativism and poor oral intake necessitated dehydration management with intravenous isotonic saline (day 24). The hypercalcemia persisted for 6 weeks. Treatment with cinacalcet (day 43) rapidly normalized the serum calcium levels (day 44). The catatonia, depression, and psychosis began resolving when clozapine (day 50) and electroconvulsive therapy (day 59) were initiated. PTH levels did not normalize until day 82. CONCLUSION: This report describes a case of prolonged hyperparathyroidism and hypercalcemia following treatment with lithium. Catatonia is unusual in patients with lithium-associated hyperparathyroidism but this report suggests that in settings yet to be determined, it is related to hypercalcemia of this syndrome.
34095485	0	7	Lithium	Chemical	MESH:D008094
34095485	19	38	Hyperparathyroidism	Disease	MESH:D006961
34095485	51	60	Catatonia	Disease	MESH:D002389
34095485	150	157	lithium	Chemical	MESH:D008094
34095485	204	211	lithium	Chemical	MESH:D008094
34095485	223	242	hyperparathyroidism	Disease	MESH:D006961
34095485	284	293	catatonia	Disease	MESH:D002389
34095485	299	306	patient	Species	9606
34095485	312	336	schizoaffective disorder	Disease	MESH:D011618
34095485	383	390	lithium	Chemical	MESH:D008094
34095485	396	403	patient	Species	9606
34095485	443	450	lithium	Chemical	MESH:D008094
34095485	479	489	creatinine	Chemical	MESH:D003404
34095485	491	498	calcium	Chemical	MESH:D002118
34095485	544	557	hypercalcemia	Disease	MESH:D006934
34095485	585	604	parathyroid hormone	Gene	5741
34095485	606	609	PTH	Gene	5741
34095485	620	627	calcium	Chemical	MESH:D002118
34095485	633	653	25-hydroxy vitamin D	Chemical	MESH:C104450
34095485	685	688	man	Species	
34095485	707	731	schizoaffective disorder	Disease	MESH:D011618
34095485	759	777	psychotic symptoms	Disease	MESH:D011618
34095485	811	822	risperidone	Chemical	MESH:D018967
34095485	827	834	lithium	Chemical	MESH:D008094
34095485	909	912	PTH	Gene	5741
34095485	959	966	calcium	Chemical	MESH:D002118
34095485	1024	1031	calcium	Chemical	MESH:D002118
34095485	1104	1111	lithium	Chemical	MESH:D008094
34095485	1121	1128	anergia	Disease	
34095485	1138	1144	mutism	Disease	MESH:D009155
34095485	1150	1159	posturing	Disease	MESH:D054972
34095485	1190	1199	catatonic	Disease	MESH:D012560
34095485	1257	1268	dehydration	Disease	MESH:D003681
34095485	1327	1340	hypercalcemia	Disease	MESH:D006934
34095485	1379	1389	cinacalcet	Chemical	MESH:D000069449
34095485	1428	1435	calcium	Chemical	MESH:D002118
34095485	1457	1466	catatonia	Disease	MESH:D002389
34095485	1468	1478	depression	Disease	MESH:D003866
34095485	1484	1493	psychosis	Disease	MESH:D011618
34095485	1515	1524	clozapine	Chemical	MESH:D003024
34095485	1589	1592	PTH	Gene	5741
34095485	1686	1705	hyperparathyroidism	Disease	MESH:D006961
34095485	1710	1723	hypercalcemia	Disease	MESH:D006934
34095485	1749	1756	lithium	Chemical	MESH:D008094
34095485	1758	1767	Catatonia	Disease	MESH:D002389
34095485	1782	1790	patients	Species	9606
34095485	1796	1803	lithium	Chemical	MESH:D008094
34095485	1815	1834	hyperparathyroidism	Disease	MESH:D006961
34095485	1916	1929	hypercalcemia	Disease	MESH:D006934
34095485	Negative_Correlation	MESH:D003024	MESH:D003866
34095485	Negative_Correlation	MESH:D000069449	MESH:D012560
34095485	Negative_Correlation	MESH:D003024	MESH:D012560
34095485	Negative_Correlation	MESH:D000069449	MESH:D006934
34095485	Negative_Correlation	MESH:D008094	MESH:D009155
34095485	Negative_Correlation	MESH:D000069449	MESH:D002389
34095485	Negative_Correlation	MESH:D000069449	MESH:D011618
34095485	Negative_Correlation	MESH:D003024	MESH:D002389
34095485	Negative_Correlation	MESH:D000069449	MESH:D002118
34095485	Positive_Correlation	MESH:D008094	MESH:D006961
34095485	Negative_Correlation	MESH:D003024	MESH:D011618
34095485	Positive_Correlation	MESH:D008094	MESH:D006934
34095485	Negative_Correlation	MESH:D000069449	MESH:D009155
34095485	Negative_Correlation	MESH:D008094	MESH:D011618
34095485	Negative_Correlation	MESH:D008094	MESH:D054972
34095485	Positive_Correlation	MESH:D008094	MESH:D002389
34095485	Negative_Correlation	MESH:D018967	MESH:D011618
34095485	Negative_Correlation	MESH:D000069449	MESH:D006961
34095485	Negative_Correlation	MESH:D000069449	MESH:D054972

